The 63 rating InvestorsObserver gives to RenovoRx Inc (RNXT) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 72 percent of stocks in the Biotechnology industry, RNXT’s 63 overall rating means the stock scores better than 63 percent of all stocks.
RNXT has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on RNXT!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 63 would rank higher than 63 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With RenovoRx Inc Stock Today?
RenovoRx Inc (RNXT) stock is trading at $2.16 as of 11:39 AM on Monday, May 15, a rise of $0.08, or 3.85% from the previous closing price of $2.08. The stock has traded between $2.13 and $2.26 so far today. Volume today is less active than usual. So far 12,104 shares have traded compared to average volume of 22,205 shares.
Click Here to get the full Stock Report for RenovoRx Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
